Coronary stent EVERMINE50

polymerdrug eluting

Ultra-low strut thickness of 50μm for promoting early vascular healing Variable strut width and variable crown design to ensure adequate radial strength of 1.1bar* Hybrid cell stent design: Open cells in the middle of the stent for side-branch access and closed cell design on ends for optimal scaffolding and conformability Clinically established drug everolimus with biodegradable polymer for proven clinical safety & long term efficacy Benefits Less vessel injury, inflammation and thrombus formation compared with thicker struts Highly deliverable and flexible in tortuous lesions Faster endothelialization and early vascular healing Monolithic stent delivery system for excellent force transmission EVERMINE50 Angioplasty - Treatment for Coronary Artery Disease Narrowing of a heart's blood vessel can result in its complete blockage and can progress gradually or can occur suddenly resulting in a heart attack, known as a myocardial infarction. Angioplasty is a procedure to widen the coronary artery and restore the blood flow